Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
- Resource Type
- Article
- Authors
- Girard, N.; Galland-Girodet, S.; Avrillon, V.; Besse, B.; Duruisseaux, M.; Cadranel, J.; Otto, J.; Prevost, A.; Roch, B.; Bennouna, J.; Bouledrak, K.; Coudurier, M.; Egenod, T.; Lamy, R.; Ricordel, C.; Moro-Sibilot, D.; Odier, L.; Tillon-Strozyk, J.; Zalcman, G.; Missy, P.; Westeel, V.; Baldacci, S.
- Source
- In ESMO Open April 2022 7(2)
- Subject
- Language
- ISSN
- 2059-7029